The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Marinella Temprosa
- Study ID
- NCT05704309
- Status
- Enrolling By Invitation
Conditions
- Alzheimer Disease
- Dementia
- Dementia, Vascular
- Diabetes
- PreDiabetes
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
The DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2 diabetes (T2D), who are a high-risk group for cognitive impairment and represent a large fraction of the United States (US) population? This U19 proposal addresses the National Alzheimer's Project Act goal to "prevent, halt, or reverse AD" in the high-risk group of persons with pre-diabetes and type 2 diabetes, who represent over half of the population aged 60 years and older in the US.
Key Dates
- Start date
- Nov 7, 2022
- Status verified
- Aug 2025
- Primary completion
- Jan 31, 2027
- Completion
- Aug 30, 2027
Study Design
- Enrollment
- 1,976 participants (estimated)
Primary Outcome Measure
Cognitive Diagnoses [ Time Frame: Sept 2022 to October 2026 ]
Locations (27)
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Alzheimer's Disease Genetics StudyRecruiting · Indiana University · Nationwide, Indiana
- Urinary Vitamin C Loss in Diabetic SubjectsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora PopulationsEnrolling By Invitation · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland